Clinical Trials Browser

Phase 2 × Mesothelioma, Malignant × ascrinvacumab × Clear all

NCT01486368 2023-08-04

A Phase II Study of PF-03446962 in Patients With Advanced Malignant Pleural Mesothelioma

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant